These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 34796013)

  • 21. Novel synthetic selectively degradable vascular prostheses: a preliminary implantation study.
    Izhar U; Schwalb H; Borman JB; Hellener GR; Hotoveli-Salomon A; Marom G; Stern T; Cohn D
    J Surg Res; 2001 Feb; 95(2):152-60. PubMed ID: 11162039
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Silyl-heparin adsorption improves the in vivo thromboresistance of carbon-coated polytetrafluoroethylene vascular grafts.
    Laredo J; Xue L; Husak VA; Ellinger J; Greisler HP
    Am J Surg; 2003 Nov; 186(5):556-60. PubMed ID: 14599625
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Physico-mechanical and biological evaluation of heparin/VEGF-loaded electrospun polycaprolactone/decellularized rat aorta extracellular matrix for small-diameter vascular grafts.
    Cuenca JP; Kang HJ; Fahad MAA; Park M; Choi M; Lee HY; Lee BT
    J Biomater Sci Polym Ed; 2022 Sep; 33(13):1664-1684. PubMed ID: 35446751
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Platelet interactions with heparin binding growth factor and fibronectin.
    Greisler HP; Klosak JJ; Steinam S; Burgess WH; Henderson SC; Cabusao EA; Ellinger J
    ASAIO Trans; 1989; 35(3):561-3. PubMed ID: 2597534
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Porcine carotid artery replacement with biodegradable electrospun poly-e-caprolactone vascular prosthesis.
    Mrówczyński W; Mugnai D; de Valence S; Tille JC; Khabiri E; Cikirikcioglu M; Möller M; Walpoth BH
    J Vasc Surg; 2014 Jan; 59(1):210-9. PubMed ID: 23707057
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Polydopamine and gelatin coating for rapid endothelialization of vascular scaffolds.
    Kopeć K; Wojasiński M; Eichler M; Genç H; Friedrich RP; Stein R; Singh R; Alexiou C; Hlawaty H; Ciach T; Cicha I
    Biomater Adv; 2022 Mar; 134():112544. PubMed ID: 35525759
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Surface-modified bioresorbable electrospun scaffolds for improving hemocompatibility of vascular grafts.
    Caracciolo PC; Rial-Hermida MI; Montini-Ballarin F; Abraham GA; Concheiro A; Alvarez-Lorenzo C
    Mater Sci Eng C Mater Biol Appl; 2017 Jun; 75():1115-1127. PubMed ID: 28415397
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Autologous fibrin-coated small-caliber vascular prostheses improve antithrombogenicity by reducing immunologic response.
    Hasegawa T; Okada K; Takano Y; Hiraishi Y; Okita Y
    J Thorac Cardiovasc Surg; 2007 May; 133(5):1268-76, 1276.e1. PubMed ID: 17467440
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Effect of different vascular prosthesis materials on blood platelets, blood clotting and fibrinolysis].
    Głowiński S; Worowski K; Worowska A; Raczyński K; Głowiński J; Kondracki S
    Polim Med; 1992; 22(4):17-29. PubMed ID: 1305964
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Characterization of a Water-Dispersed Biodegradable Polyurethane-Silk Composite Sponge Using
    Tanaka T; Ibe Y; Jono T; Tanaka R; Naito A; Asakura T
    Molecules; 2021 Jul; 26(15):. PubMed ID: 34361802
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Fabrication of permeable tubular constructs from chemically modified chitosan with enhanced antithrombogenic property.
    Qiu Y; Zhang N; Kang Q; An Y; Wen X
    J Biomed Mater Res B Appl Biomater; 2009 Aug; 90(2):668-78. PubMed ID: 19213048
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Reduced thrombogenicity of vascular prostheses by coating with ADP-ase.
    van der Lei B; Bartels HL; Robinson PH; Bakker WW
    Int Angiol; 1992; 11(4):268-71. PubMed ID: 1295932
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Heparin Immobilization of Tissue Engineered Xenogeneic Small Diameter Arterial Scaffold Improve Endothelialization.
    Tardalkar K; Marsale T; Bhamare N; Kshersagar J; Chaudhari L; Joshi MG
    Tissue Eng Regen Med; 2022 Jun; 19(3):505-523. PubMed ID: 35092597
    [TBL] [Abstract][Full Text] [Related]  

  • 34. In vivo platelet deposition on polytetrafluoroethylene coated with fibrin glue containing fibroblast growth factor 1 and heparin in a canine model.
    Gosselin C; Ren D; Ellinger J; Greisler HP
    Am J Surg; 1995 Aug; 170(2):126-30. PubMed ID: 7543261
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Low-thrombogenic fibrin-heparin coating promotes in vitro endothelialization.
    Kaplan O; Hierlemann T; Krajewski S; Kurz J; Nevoralová M; Houska M; Riedel T; Riedelová Z; Zárubová J; Wendel HP; Brynda E
    J Biomed Mater Res A; 2017 Nov; 105(11):2995-3005. PubMed ID: 28646555
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Surface Coating of Polyurethane Films with Gelatin, Aspirin and Heparin to Increase the Hemocompatibility of Artificial Vascular Grafts.
    Hosseinzadeh S; Shams F; Fattahi R; Nuoroozi G; Rostami E; Shahghasempour L; Salehi-Nik N; Bohlouli M; Khojasteh A; Ghasemi N; Peiravi H
    Adv Pharm Bull; 2023 Jan; 13(1):123-133. PubMed ID: 36721809
    [No Abstract]   [Full Text] [Related]  

  • 37. Acute thrombogenicity of arterial prostheses exposed to reduced blood flow in dogs: effects of heparin, aspirin, and prostacyclin.
    Merhi Y; Bernier J; Marois Y; Guidoin R
    J Cardiovasc Pharmacol; 1995 Jul; 26(1):1-5. PubMed ID: 7564348
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Platelet deposition on ePTFE grafts coated with fibrin glue with or without FGF-1 and heparin.
    Zarge JI; Gosselin C; Huang P; Vorp DA; Severyn DA; Greisler HP
    J Surg Res; 1997 Jan; 67(1):4-8. PubMed ID: 9070173
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prevention of platelet adhesion and aggregation by a glutardialdehyde-stabilized heparin surface.
    Olsson P; Lagergren H; Larsson R; Rådegran K
    Thromb Haemost; 1977 Apr; 37(2):274-82. PubMed ID: 577629
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Heparin immobilized on proteins usable for arterial prosthesis coating: growth inhibition of smooth-muscle cells.
    Laemmel E; Penhoat J; Warocquier-Clérout R; Sigot-Luizard MF
    J Biomed Mater Res; 1998 Mar; 39(3):446-52. PubMed ID: 9468054
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.